Humacyte Interest Expense from 2010 to 2024

HUMAW Stock  USD 1.71  0.24  16.33%   
Humacyte Interest Expense yearly trend continues to be fairly stable with very little volatility. Interest Expense will likely drop to about 1.1 M in 2024. Interest Expense is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. View All Fundamentals
 
Interest Expense  
First Reported
2010-12-31
Previous Quarter
1.1 M
Current Value
1.1 M
Quarterly Volatility
1.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Humacyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Humacyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.7 M, Interest Expense of 1.1 M or Selling General Administrative of 21.1 M, as well as many indicators such as Price To Sales Ratio of 96.95, Dividend Yield of 0.0 or PTB Ratio of 22.77. Humacyte financial statements analysis is a perfect complement when working with Humacyte Valuation or Volatility modules.
  
Check out the analysis of Humacyte Correlation against competitors.
For more information on how to buy Humacyte Stock please use our How to Invest in Humacyte guide.

Latest Humacyte's Interest Expense Growth Pattern

Below is the plot of the Interest Expense of Humacyte over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. Humacyte's Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Humacyte's overall financial position and show how it may be relating to other accounts over time.
Interest Expense10 Years Trend
Pretty Stable
   Interest Expense   
       Timeline  

Humacyte Interest Expense Regression Statistics

Arithmetic Mean2,529,160
Geometric Mean2,316,475
Coefficient Of Variation48.99
Mean Deviation731,957
Median2,298,000
Standard Deviation1,238,954
Sample Variance1.5T
Range5.1M
R-Value0.15
Mean Square Error1.6T
R-Squared0.02
Significance0.59
Slope42,385
Total Sum of Squares21.5T

Humacyte Interest Expense History

20241.1 M
20231.1 M
20226.2 M
20214.3 M
20202.2 M

About Humacyte Financial Statements

Humacyte investors use historical fundamental indicators, such as Humacyte's Interest Expense, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Humacyte. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Interest Expense1.1 M1.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Humacyte Stock Analysis

When running Humacyte's price analysis, check to measure Humacyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humacyte is operating at the current time. Most of Humacyte's value examination focuses on studying past and present price action to predict the probability of Humacyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Humacyte's price. Additionally, you may evaluate how the addition of Humacyte to your portfolios can decrease your overall portfolio volatility.